Healthtech Startups

VETSTOR develops technology for pet health management using data-driven approaches. The company serves veterinary and pet care providers in the animal health industry.

1 investor

VetStrategy is the leading veterinary network in Canada, operating veterinary practices, 24-hour emergency care facilities, and specialty hospitals across the country. The company is built on commitments to delivering world-class veterinary care locally, being a great workplace, and supporting sustainability.

1 investor

VettyPet is a white-label e-commerce platform for veterinary clinics that supports clinic operations, client communication, and product sales, while also offering vet-approved products to pet owners. It serves veterinarians and pet parents in the animal health and pet care industry.

1 investor

VetVet is a brokerage firm specializing in helping veterinary practice owners sell their businesses by managing due diligence, buyer matching, negotiation, and valuation. The service targets small business owners in the veterinary sector seeking strategic guidance and top-market outcomes for their practice sales.

1 investor

Veyo provides technology for managing non-emergency medical transportation (NEMT) benefits, adapting consumer rideshare innovations such as real-time dashboards, supply-demand matching, and driver apps to healthcare. It serves health plan members, transportation providers, and medical facility partners, integrating rideshare fleets with provider partners to lower costs and improve response times.

1 investor

Vflok offers Swift, an agentic AI platform that automates nurse and support-team scheduling and staffing workflows, such as filling open shifts, handling swaps, and messaging staff via SMS/chat. It targets hospital nursing and support teams, including nurse managers and unit/facility staffing teams, and was developed in partnership with Wellstar Health System.

1 investor

VFlow21 develops next-generation vascular stents and a patent-protected delivery system for brain endovascular treatments across arterial and venous applications. The company was established in 2021 and has been granted funding by the Israel Innovation Authority.

1 investor

Via is a real-time operating system for hospitals that connects clinical decisions, operational performance and financial outcomes, unifying data from EHRs, ERPs and analytics tools. Its core clinical intelligence engine, CliniGraph, reads full clinical encounters to build comparable patient populations and surface insights physicians can act on.

1 investor

ViaLase develops the ViaLase Laser System, a femtosecond laser and HD imaging platform for noninvasive interventional glaucoma treatment that creates apertures through the trabecular meshwork in patients with open-angle glaucoma. The technology, used via its FLigHT procedure, is aimed at ophthalmic surgeons treating glaucoma without incisional surgery.

1 investor

Viamet provides a resource for people to organize questions and conduct research about medical travel, provider verification, care coordination, and health-related travel planning. The platform helps users compare options and think through decisions before committing resources to medical tourism or wellness travel projects.

1 investor

VIAN Therapeutics develops a topical eye drop treatment for retinal diseases caused by angiogenesis and vascular permeability, offering a non-invasive alternative to intravitreal injections. The lead candidate targets age-related macular degeneration and diabetic macular edema by inhibiting pro-angiogenic factors and inflammatory cytokines.

1 investor

Claritev provides AI-enabled healthcare data and analytics solutions that help brokers, employers, agencies, TPAs, and enterprises reduce costs, improve payment accuracy, and increase price transparency. Its offerings span payment integrity, cost containment, and operational intelligence across the healthcare system.

1 investor

ViaPath Technologies provides communications, education, and technology solutions for correctional facilities, incarcerated individuals, and their families. The company operates secure digital communications platforms, educational tools, payment processing, and data intelligence systems across North America, the UK, and Australia.

1 investor

ViaQuest provides healthcare and support services including behavioral health, psychiatric services, residential and supported living, and day and employment services for individuals with intellectual and developmental disabilities. It operates in states including Ohio and Indiana.

1 investor

Via Sana provides turnkey, fully equipped medical and paramedical offices for healthcare professionals in private practice, offered under a fixed monthly flat rate covering equipment, maintenance, cleaning, insurance, internet and consumables. It offers flexible rental terms (full-time, part-time or hourly), support services such as secretarial help, booking software and payment terminals, and access to a multidisciplinary community of practitioners.

1 investor

Vibrato Medical develops wearable therapeutic ultrasound devices for treating peripheral artery disease. The company focuses on bringing medical device technology from development through clinical trials and regulatory approval.

1 investor

Vibronix develops medical diagnostic and treatment technology that combines vibrational spectroscopic imaging, optical and acoustic sensing, and machine learning for precision healthcare applications.

1 investor

VIC Rewards operates a utility token-based rewards program built on a private healthcare blockchain, designed to incentivize patients to adhere to personalized care plans while enabling healthcare providers and organizations to collaborate within integrated healthcare ecosystems. The platform targets healthcare consumers, providers, and organizations seeking to improve health outcomes and reduce costs through patient-centered care coordination.

1 investor

1 investor

Vicore Pharma is a clinical-stage biopharmaceutical company developing disease-modifying treatments for respiratory and fibrotic diseases, including idiopathic pulmonary fibrosis. The company's lead program, buloxibutid, is an oral small molecule in Phase 2b clinical trials.

1 investor

Safetest develops, produces, and sells rapid lateral-flow diagnostic test kits for detecting human diseases through isolation of specific antigens, and offers R&D, antigen/antibody conjugation services, training, and technical support. It positions itself as a Brazilian company making fully domestically produced rapid diagnostic tests for researchers, companies, and healthcare applications.

1 investor

VIDA provides AI-powered imaging biomarkers and clinical trial imaging services, using its VIDA Intelligence Platform to collect and analyze imaging data across respiratory, cardiovascular, oncology, and other therapeutic areas. It serves drug developers and clinical trial sponsors in the life sciences industry with quantitative image analysis, expert reading services, and digital biobank capabilities.

1 investor

Vidcare provides chronic disease management solutions through rapid testing and clinical tools designed to reduce repeat doctor visits and improve healthcare provider efficiency.

1 investor

Viedial helps individuals identify cardiovascular disease risk factors and manage them through personalized care plans supported by family and friends. The platform enables users to track health changes and monitor disease progression from any location.

1 investor